| Terminated |
: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
: - B-cell Chronic Lymphocytic Leukemia
- Prolymphocytic Leukemia
-
- Drug: alvespimycin hydrochloride
|
| Active, not recruiting |
: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
: - Prolymphocytic Leukemia
- Recurrent Small Lymphocytic Lymphoma
-
- Drug: ibrutinib Patients recei
|
| Active, not recruiting |
: Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia or B-Cell Prolymphocytic Leukemia
: - Post-transplant Lymphoproliferative Disorder
- B-Cell Prolymphocytic Leu
: 2014-05-30
: - Drug: cyclophosphamide Given I
|
| Active, not recruiting |
: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
: - Chronic Lymphocytic Leukemia
- Prolymphocytic Leukemia
- Recur
: 2012-01-16
: - Drug: Dinaciclib Given IV
|
| Recruiting |
: Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
: - B-Cell Prolymphocytic Leukemia
- Recurrent Chronic Lymphocytic Le
: 2013-06-24
:
|
| Recruiting |
: PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
: - Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Fo
: 2016-09-02
: Biological: anti-CD19 CAR-NK cells The allogeneic NK cells (NK-92 cell line for clinical use) are engine
|
| Recruiting |
: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
: - Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Fo
: 2016-07-28
: Biological: PCAR-019 (anti-CD19 CAR-T cells) Other Name: chimeric antigen receptor T cells with specific
|
| Recruiting |
: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
: - Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Fo
: 2016-06-28
: Biological: PCAR-019 (anti-CD19 CAR-T cells) Other Name: chimeric antigen receptor T cells with specific
|
| Recruiting |
: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
: - B-Cell Prolymphocytic Leukemia
- Hypodiploidy
-
- Procedure: Allogeneic Bone Marrow Transplantation
|
| Active, not recruiting |
: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
: - B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
: 2003-05-06
: - Drug: Cyclosporine Given PO
|
